I recently individually interviewed 10 biotech CEOs and 10 biotech venture capitalists as part of the data collection portion of an executive coaching engagement. It wasn’t the subject of the interview – which was to collect feedback data regarding my coaching client – but everyone to a person brought up the subject of venture capital and biotech.
Everyone talked about the model of investment and development that’s been in existence since Genentech (1976) and Amgen (1980) were founded.… Read the rest